In our previous study, immunohistochemistry revealed that SerpinB2 protein is highly expressed in tumor cells in aggressive breast tumor tissue with the triple-negative subtype, and is associated with a short overall survival in breast cancer patients [4]. This evidence concerns the gene SERPINB2 and breast neoplasm.